VOR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	244 387
Average Volume	302 114
Market Cap	92.15M
EPS	$0 ( 2024-05-23 )
Next earnings date	( $-0.410 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.760
ATR14	$0.00100 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-23	Namouni Fouad	Buy	30 000	Stock Option (Right to Buy)
2024-05-23	Beckman Daniella	Buy	30 000	Stock Option (Right to Buy)
2024-05-23	Lundberg Sven Ante	Buy	30 000	Stock Option (Right to Buy)
2024-05-23	Lubner David Charles	Buy	30 000	Stock Option (Right to Buy)
2024-05-23	Patterson Matthew R	Buy	30 000	Stock Option (Right to Buy)

INSIDER POWER
97.15
Last 98 transactions
Buy: 26 623 982 \| Sell: 4 630 671

Volume Correlation

Long: -0.13 (neutral)

Short: 0.63 (weak)

Signal:(52.247) Neutral

Vor Biopharma Inc. Correlation

10 Most Positive Correlations
PERI	0.839
AKAN	0.828
NUTX	0.824
PIXY	0.823
INCY	0.817
CMLS	0.816
SONM	0.815
SIRI	0.813
BYFC	0.812
GILD	0.811

10 Most Negative Correlations
BSCO	-0.835
RVMD	-0.835
PRIM	-0.828
BOCN	-0.826
IGTA	-0.82
PIE	-0.818
NKTR	-0.817
APXI	-0.815
ALPN	-0.811
SKYW	-0.81

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vor Biopharma Inc. Correlation - Currency/Commodity

0.77
( moderate )

0.84
( strong )

0.00
( neutral )

0.46
( neutral )

-0.23
( neutral )

Vor Biopharma Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-3.49M (0.00 %)
EPS:	$-1.750

FY	2023
Revenue:	$0
Gross Profit:	$-3.49M (0.00 %)
EPS:	$-1.750

FY	2022
Revenue:	$0
Gross Profit:	$-8.96M (0.00 %)
EPS:	$-2.29

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Vor Biopharma Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Vor Biopharma Inc.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.